Geode Capital Management
SILK

Geode Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Geode Capital Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-897,661
Closed -$24.3M – 4603
2024
Q2 		$24.3M Buy
897,661
+19,811
+2% +$412K ﹤0.01% 1829
2024
Q1 		$16.1M Buy
877,850
+17,588
+2% +$279K ﹤0.01% 2051
2023
Q4 		$10.6M Buy
860,262
+45,568
+6% +$427K ﹤0.01% 2316
2023
Q3 		$12.2M Buy
814,694
+47,276
+6% +$984K ﹤0.01% 2134
2023
Q2 		$24.9M Buy
767,418
+42,087
+6% +$1.54M ﹤0.01% 1706
2023
Q1 		$28.4M Buy
725,331
+33,968
+5% +$1.66M ﹤0.01% 1571
2022
Q4 		$36.5M Buy
691,363
+71,345
+12% +$3.47M 0.01% 1368
2022
Q3 		$27.9M Buy
620,018
+13,565
+2% +$583K ﹤0.01% 1509
2022
Q2 		$22.1M Sell
606,453
-12,305
-2% -$447K ﹤0.01% 1697
2022
Q1 		$25.5M Buy
618,758
+14,000
+2% +$493K ﹤0.01% 1718
2021
Q4 		$25.8M Sell
604,758
-6,501
-1% -$325K ﹤0.01% 1785
2021
Q3 		$33.6M Buy
611,259
+21,200
+4% +$1.11M ﹤0.01% 1604
2021
Q2 		$28.2M Buy
590,059
+69,545
+13% +$3.54M ﹤0.01% 1731
2021
Q1 		$26.4M Buy
520,514
+43,624
+9% +$2.42M ﹤0.01% 1698
2020
Q4 		$30M Buy
476,890
+20,628
+5% +$1.28M 0.01% 1456
2020
Q3 		$30.7M Buy
456,262
+128,620
+39% +$7.02M 0.01% 1210
2020
Q2 		$13.7M Buy
327,642
+154,766
+90% +$5.94M ﹤0.01% 1743
2020
Q1 		$5.44M Buy
172,876
+30,888
+22% +$1.24M ﹤0.01% 2097
2019
Q4 		$5.73M Buy
141,988
+24,557
+21% +$860K ﹤0.01% 2367
2019
Q3 		$3.82M Buy
117,431
+27,736
+31% +$1.1M ﹤0.01% 2546
2019
Q2 		$4.35M Buy
+89,695
New +$3.81M ﹤0.01% 2486

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geode Capital Management's SILK Position: Q3 2024 in Review

Geode Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 897,661 shares — an estimated $24.3M sold.

Geode Capital Management first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $36.5M in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Geode Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Geode Capital Management sold 897,661 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $24.3M.
  • Geode Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
  • Geode Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $36.5M in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.